Phycomycosis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 33: | Line 33: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
<gallery> | |||
File:Pythiosis_2.jpg|Pythiosis lesion on skin | |||
File:Pythiosis_hyphae.jpg|Hyphae of Pythium insidiosum | |||
File:Mature_sporangium_of_a_Mucor_sp._fungus.jpg|Mature sporangium of a Mucor species fungus | |||
</gallery> | |||
Revision as of 01:23, 18 February 2025
Phycomycosis is a type of fungal infection that affects both humans and animals. It is caused by various species of fungi in the order Mucorales. The disease is characterized by the formation of large, non-healing ulcers, often with a necrotic center and raised, indurated margins.
Etiology
Phycomycosis is caused by various species of fungi in the order Mucorales. These fungi are ubiquitous in the environment and are commonly found in soil, decaying organic matter, and the gastrointestinal tract of animals. Infection usually occurs through inhalation of fungal spores or direct inoculation into the skin or mucous membranes.
Clinical Presentation
The clinical presentation of phycomycosis can vary depending on the site of infection. Cutaneous phycomycosis presents as large, non-healing ulcers, often with a necrotic center and raised, indurated margins. Pulmonary phycomycosis can present with cough, fever, and hemoptysis. Gastrointestinal phycomycosis can present with abdominal pain, nausea, vomiting, and diarrhea.
Diagnosis
Diagnosis of phycomycosis is based on clinical presentation, histopathological examination, and culture of the fungus. Histopathological examination typically shows broad, non-septate hyphae with right-angle branching. Culture of the fungus can be performed on Sabouraud's agar.
Treatment
Treatment of phycomycosis involves surgical debridement of the infected tissue and antifungal therapy. The antifungal drug of choice is amphotericin B. In severe cases, combination therapy with other antifungal drugs may be required.
Prognosis
The prognosis of phycomycosis is generally poor, especially in immunocompromised patients. Early diagnosis and aggressive treatment can improve the prognosis.
